[HTML][HTML] GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential

X Ma, Z Liu, I Ilyas, PJ Little, D Kamato… - … journal of biological …, 2021 - ncbi.nlm.nih.gov
Type 2 diabetes mellitus (T2DM) is closely associated with cardiovascular diseases (CVD),
including atherosclerosis, hypertension and heart failure. Some anti-diabetic medications …

[HTML][HTML] A bibliometric and knowledge-map analysis of macrophage polarization in atherosclerosis from 2001 to 2021

L Song, J Zhang, D Ma, Y Fan, R Lai, W Tian… - Frontiers in …, 2022 - frontiersin.org
In recent years, studies of macrophage polarization in atherosclerosis have become an
intense area of research. However, there are few bibliometric analyses regarding this area …

[HTML][HTML] The multifaceted roles of macrophages in NAFLD pathogenesis

J Vonderlin, T Chavakis, M Sieweke, F Tacke - Cellular and Molecular …, 2023 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is the liver manifestation of the metabolic
syndrome. NAFLD constitutes a spectrum of pathologies ranging from simple hepatic …

[HTML][HTML] GLP-1 receptor agonist as a modulator of innate immunity

J Chen, A Mei, Y Wei, C Li, H Qian, X Min… - Frontiers in …, 2022 - frontiersin.org
Glucagon-like peptide-1 (GLP-1) is a 30-amino acid hormone secreted by L cells in the
distal ileum, colon, and pancreatic α cells, which participates in blood sugar regulation by …

[HTML][HTML] Glucocorticoids as regulators of macrophage-mediated tissue homeostasis

D Diaz-Jimenez, JP Kolb, JA Cidlowski - Frontiers in immunology, 2021 - frontiersin.org
Our immune system has evolved as a complex network of cells and tissues tasked with
maintaining host homeostasis. This is evident during the inflammatory responses elicited …

Emerging roles of Glucagon like peptide-1 in the management of autoimmune diseases and diabetes-associated comorbidities

S Shao, X Zhang, Q Xu, R Pan, Y Chen - Pharmacology & Therapeutics, 2022 - Elsevier
Currently, gastrointestinal hormone glucagon like peptide-1 (GLP-1) has received significant
attention in maintaining glucose homeostasis through mechanisms involving augmentation …

[HTML][HTML] Research progress on classical traditional Chinese medicine Taohong Siwu decoction in the treatment of coronary heart disease

XZ Wang, T Wang, YZ Wang, X Li, Q Chen… - Biomedicine & …, 2022 - Elsevier
The pathogenesis of coronary heart disease is closely related to blood stasis. Taohong Siwu
decoction (THSW for short) is one of the most widely used prescriptions for activating blood …

[HTML][HTML] Nonalcoholic steatohepatitis (NASH) and atherosclerosis: explaining their pathophysiology, association and the role of incretin-based drugs

E Galatou, E Mourelatou, S Hatziantoniou… - Antioxidants, 2022 - mdpi.com
Nonalcoholic steatohepatitis (NASH) is the most severe manifestation of nonalcoholic fatty
liver disease (NAFLD), a common complication of type 2 diabetes, and may lead to cirrhosis …

[HTML][HTML] Therapeutic strategies targeting mechanisms of macrophages in diabetic heart disease

C Zhang, Y Shi, C Liu, SM Sudesh, Z Hu, P Li… - Cardiovascular …, 2024 - Springer
Diabetic heart disease (DHD) is a serious complication in patients with diabetes. Despite
numerous studies on the pathogenic mechanisms and therapeutic targets of DHD, effective …

[HTML][HTML] Thiazolidinediones play a positive role in the vascular endothelium and inhibit plaque progression in diabetic patients with coronary atherosclerosis: A …

CY Xue, MQ Zhou, QY Zheng, JH Zhang… - Frontiers in …, 2022 - frontiersin.org
Rosiglitazone (Avandia) and pioglitazone (Actos) belong to the class of thiazolidinediones
(TZDs) drugs that act by increasing insulin sensitivity and are widely used for treating …